This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts. Just because implantable defibrillators have been found to prevent ...
Results from Optimizing Beta-Blocker Dosage in Female Patients Using the Wearable Cardioverter Defibrillator (OPT-BB Women) were presented at ESC-HF 2026 ZOLL®, an Asahi Kasei company that ...
Among patients with advanced HFrEF, women, compared with men, are less likely to receive an implantable cardiac defibrillator. Women who have advanced heart failure with reduced ejection fraction ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results